Ph3 Study of Exemestane With or Without Entinostat in Chinese Patients With Hormone Receptor-Positive, Locally Advanced or Metastatic Breast Cancer

NCT03538171 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

375

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Breast Cancer

Interventions

DRUG: Entinostat
DRUG: Placebo
DRUG: Exemestane

Sponsor

Taizhou EOC Pharma Co., Ltd.